Regenxbio (RGNX) Other Working Capital Changes (2014 - 2025)

Regenxbio's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at $3.3 million for Q4 2018.

• On a quarterly basis, Other Working Capital Changes changed N/A year-over-year to $3.3 million in Q4 2018; TTM through Dec 2018 was $3.3 million, a N/A change from a year earlier, with the FY2018 full-year figure at $3.9 million, changed N/A from the prior year.
• Other Working Capital Changes advanced to $3.3 million in Q4 2018 per RGNX's latest filing, from -$35000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $39.8 million in Q1 2025 and bottomed at -$44.2 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is -$82000.0 (2024), against an average of $447750.0.
• Biggest YoY gain for Other Working Capital Changes was 29559.26% in 2025; the steepest drop was 48903.45% in 2025.
• Year by year, Other Working Capital Changes stood at -$15000.0 in 2014, then jumped by 66.67% to -$5000.0 in 2015, then tumbled by 600.0% to -$35000.0 in 2016, then soared by 9622.86% to $3.3 million in 2018.
• Per Business Quant, the three latest RGNX Other Working Capital Changes figures stand at $3.3 million (Q4 2018), -$35000.0 (Q2 2016), and -$92000.0 (Q1 2016).